Agilent Technologies, Inc. (A)
$
146.32
-1.67 (-1.14%)
Key metrics
Financial statements
Free cash flow per share
4.0707
Market cap
41.5 Billion
Price to sales ratio
5.9703
Debt to equity
0.4976
Current ratio
1.9574
Income quality
1.1965
Average inventory
1 Billion
ROE
0.2062
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilent Technologies, Inc. provides application-focused solutions to life sciences, diagnostics, and applied chemical markets globally. The Life Sciences and Applied Markets segment delivers a wide array of analytical instruments and systems, including liquid chromatography systems and components, mass spectrometry systems, gas chromatography systems, and various spectroscopy technologies. The company's innovative approach is evident in its diverse offerings such as cell analysis plate-based assays, flow cytometers, laboratory automation tools, and dissolution testing equipment. Additionally, Agilent incurred an interest expense of $112,000,000.00 reflecting its debt servicing obligations. The gross profit ratio is 0.52 which highlights the efficiency of the company's production and sales operations. Furthermore, the diluted EPS is $4.57 accounting for potential share dilution, while the net income ratio stands at 0.19 demonstrating the company's profitability margin. The reported depreciation and amortization expenses amount to $288,000,000.00 underscoring the wear and tear of its assets. On the diagnostics front, Agilent offers advanced technologies for DNA analysis, including arrays for mutation detection and next-generation sequencing, along with reagents for turbidimetry. In addition, Agilent CrossLab segment delivers essential laboratory supplies and services such as custom chemistries and sample preparation products. The stock is reasonably priced at $126.32 appealing to a broad range of investors. With a high average trading volume of 1,908,483.00 there is strong liquidity in the stock, making it an attractive option for market participants. The company showcases a mid-range market capitalization of $41,481,782,186.00 positioning it as a steady performer within the sector. As a key player in the Medical - Diagnostics & Research industry, Agilent significantly contributes to the overall market landscape, driving innovation and growth within the Healthcare sector. Its comprehensive range of products is marketed through direct sales, distributors, and electronic commerce, ensuring a broad reach in delivering its advanced solutions to a global clientele.
Is Agilent Technologies, Inc. (A) a good investment?
Investing in Agilent Technologies, Inc. (A) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
What is Agilent Technologies, Inc. (A)'s stock forecast?
Analysts predict Agilent Technologies, Inc. stock to fluctuate between $96.43 (low) and $160.27 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Agilent Technologies, Inc.'s market capitalization?
As of 2026-01-13, Agilent Technologies, Inc.'s market cap is $41,481,782,186, based on 283,500,425 outstanding shares.
How does Agilent Technologies, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Agilent Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Agilent Technologies, Inc. pay dividends?
Agilent Technologies, Inc. pays dividends. The current dividend yield is 0.68%, with a payout of $0.26 per share.
How can I buy Agilent Technologies, Inc. (A) stock?
To buy Agilent Technologies, Inc. (A) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for A. Place an order (Market, Limit, etc.).
What is the best time to invest in Agilent Technologies, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Agilent Technologies, Inc. stock ever split?
Agilent Technologies, Inc.'s last stock split was 699:500 on 2014-11-03.
How did Agilent Technologies, Inc. perform in the last earnings report?
Revenue: $6,948,000,000 | EPS: $4.59 | Growth: 3.38%.
Where can I find Agilent Technologies, Inc.'s investor relations reports?
Visit https://www.agilent.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Agilent Technologies, Inc.?
You can explore historical data from here
What is the all-time high and low for Agilent Technologies, Inc. stock?
All-time high: $179.57 (2021-09-03) | All-time low: $96.43 (2025-04-09).
What are the key trends affecting Agilent Technologies, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
zacks.com
Agilent (A) reported earnings 30 days ago. What's next for the stock?
seekingalpha.com
Bloomberg's 2026 Dividend Focus list highlights 14 ‘safer' stocks with free cash flow yields exceeding dividend yields, signaling potential buy opportunities. Top projected net gainers for 2026 include Marvell Technology (MRVL), Nike (NKE), and PT Telekom Indonesia (TLK), with analyst-estimated gains up to 37.98%. Four ‘IDEAL' stocks—Aviva, Sodexo, Danske Bank, and Western Midstream—offer dividends from $1,000 invested greater than their share price, meeting the dogcatcher ‘watch to buy' threshold.
businesswire.com
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will present at the 44th Annual J.P. Morgan Healthcare Conference at 9 to 9:40 a.m. PST on Tuesday, Jan. 13, 2026. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations website. About Agilent Technologies Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technolog.
seekingalpha.com
Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
247wallst.com
The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.
seekingalpha.com
Agilent Technologies delivered strong Q4 2025 results, with revenue and EPS beating expectations and robust growth in Life Sciences and Diagnostics segment. Management forecasts FY26 revenue growth of 6% and normalized EPS between $5.86 and $6.00, signaling continued solid performance. Agilent now trades at a 6% premium to fair value after a 23% rally, outpacing the S&P 500 handily since my August coverage.
zacks.com
A report higher Q4 revenues and lifts its 2026 outlook, yet the stock slips as margins narrow across key business segments.
benzinga.com
Agilent Technologies Inc (NYSE: A) reported upbeat earnings for the fourth quarter on Monday.
seekingalpha.com
Agilent Technologies, Inc. ( A ) Q4 2025 Earnings Call November 24, 2025 4:30 PM EST Company Participants Tejas Savant Padraig McDonnell - CEO, President & Director Adam Elinoff - Senior VP, CFO & Principal Financial Officer Rodney Gonsalves - Principal Accounting Officer, VP & Corporate Controller Simon May - SVP & President of LDG Angelica Riemann - Senior VP & President of Agilent CrossLab Group Mike Zhang - Senior VP & President of Applied Markets Group Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Daniel Leonard - UBS Investment Bank, Research Division Douglas Schenkel - Wolfe Research, LLC Brandon Couillard - Wells Fargo Securities, LLC, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jack Meehan - Nephron Research LLC Daniel Brennan - TD Cowen, Research Division Michael Ryskin - BofA Securities, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Luke Sergott - Barclays Bank PLC, Research Division Presentation Operator Good afternoon.
See all news
